425.453.0404

US FDA Approved Clinical Trials for Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathy

NP07: A Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Diabetic Peripheral Neuropathic Pain

NCT07285018

Vertex VX24-548-110A: Phase 3, Randomized, Double-blind, Placebo- and Active-Controlled Study of the Efficacy and Safety of Suzetrigine in Subjects with Pain Associated with Diabetic Peripheral Neuropathy

NCT06628908

Study Evaluation Process

  • Screening: Determine eligibility and safety through medical examinations, questionnaires, and interviews.
  • Informed Consent: Receive detailed information about the trial, including risks and benefits.
  • Treatment: Receive investigational medication and placebo, and follow the trail protocol regarding current treatments and medications.
  • Monitoring: Close monitoring of conditions and side effects through check-ups, laboratory tests, EKG’s and assessments.

NWCRC in Bellevue, WA. Research and medical studies patient lounge.

CONTACT US

To be contacted about this study, fill out the contact form or call 425-453-0404.

This field is for validation purposes and should be left unchanged.
We complete all visits in person. Do you live within 50 miles of Bellevue, WA?(Required)


Are you interested in participating in clinical trials?(Required)


Please indicated which study you are interested in.(Required)